FIELD: medicine.
SUBSTANCE: invention relates to an allosteric pharmacological chaperone that restores the function of glucocerebrosidase, from the class of N,O-disubstituted sacylyloyl hydrazine derivatives, general formula.
EFFECT: creation of a new compound that restores the function of glucocerebrosidase due to allosteric regulation, which can be used in medicine for the treatment of Gaucher disease and Parkinson's disease.
1 cl, 5 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIAGNOSING PARKINSON'S DISEASE ASSOCIATED WITH MUTATIONS IN GLUCOCEREBROSIDASE (GBA) GENE | 2020 |
|
RU2750357C1 |
| ARIMOCLOMOL FOR TREATMENT OF GLUCOCEREBROSIDASE-ASSOCIATED DISORDERS | 2017 |
|
RU2750154C2 |
| NEUROPHYSIOLOGICAL MODEL OF NERVOUS SYSTEM POSSESSING REVERBERATION PROPERTIES, AND METHOD FOR CREATION THEREOF | 2019 |
|
RU2723612C1 |
| METHOD FOR PROTECTING NEURONS IN NEURODEGENERATIVE DISEASES AND APPARATUS FOR IMPLEMENTATION THEREOF | 2021 |
|
RU2783111C1 |
| METHOD FOR PRODUCING ex vivo ALVEOLAR MACROPHAGE CULTURES OF THE OPERATIONAL MATERIAL OF PATIENTS SUFFERING PULMONARY TUBERCULOSIS AND METHOD FOR ESTIMATING VIRULENCE OF Mycobacterium tuberculosis USING THE OBTAINED ex vivo ALVEOLAR MACROPHAGE CULTURES | 2015 |
|
RU2593725C1 |
| METHOD FOR ASSESSING THE BALANCE OF THE IMMUNE, INFLAMMATORY AND ANTI-INFLAMMATORY REACTION OF ALVEOLAR MACROPHAGES RECOVERED FROM RESECTED PARTS OF THE LUNG OF PATIENTS SUFFERING PULMONARY TUBERCULOSIS, DEPENDING ON THE DEGREE OF MYCOBACTERIUM TUBERCULOSIS MACROPHAGES INFECTION | 2019 |
|
RU2712946C1 |
| ANALGESIC SUBSTANCE OF ENDOGENOUS NATURE, PHARMACEUTICAL COMPOSITION BASED THEREON AND METHODS OF USE THEREOF | 2023 |
|
RU2823100C2 |
| METHOD OF DETERMINING PECULIARITIES OF EPILEPSIA COURSE BASING ON PHYSIOLOGICAL INDICATORS BY METHOD OF LOGIT-REGRESSION ANALYSIS | 2016 |
|
RU2637297C1 |
| AGENT HAVING A PROPERTY TO PREVENT DEATH OF GABA-ERGIC NEURONS IN CONDITIONS OF ACUTE PERINATAL HYPOXIA | 2017 |
|
RU2672918C1 |
| METHOD FOR DETERMINING THE ABILITY OF MYCOBACTERIA OF TUBERCULOSIS TO GROWTH IN ALVEOLAR MACROPHAGES OF PATIENTS AFTER THE COURSE OF ANTITUBERCULOSIS THERAPY | 2017 |
|
RU2652882C1 |
